-Reuters
Chief Executive Officer Of Alignment Healthcare Makes $3.7M Sale
John E Kao, Chief Executive Officer at Alignment Healthcare (NASDAQ:ALHC), made a large insider sell on October 14, according to a new SEC filing.
Related Posts
JP Morgan Upgrades Gilead Sciences to Overweight, Raises Price Target to $80
JP Morgan analyst Chris Schott upgrades Gilead Sciences (NASDAQ:GILD) from Neutral to Overweight and raises the price target from $72 to $80.
Staffing 360 Solutions Q2 EPS $(1.29) Down From $7.50 YoY
Staffing 360 Solutions (NASDAQ:STAF) reported quarterly losses of $(1.29) per share. This is a 117.2 percent decrease over earnings of $7.50 per share from the same period last year.
Wells Fargo Maintains Overweight on Integral Ad Science, Lowers Price Target to $15
Wells Fargo analyst Brian Fitzgerald maintains Integral Ad Science (NASDAQ:IAS) with a Overweight and lowers the price target from $16 to $15.